Bone Health Awareness Sale ends in 00days 00hrs 00min
← Learn

Can You Take Shilajit If You Are on Blood Thinners?

October 4, 2026 · Optimum Research Team
Can You Take Shilajit If You Are on Blood Thinners?

In this article

  • Where does the shilajit and blood thinner warning actually come from?
  • What did the original 1990s lab study measure?
  • Did the effect even point the direction people assume?
  • What happened when researchers tried it by mouth in a living animal?
  • How much fulvic acid would it take to match the lab concentration?
  • What does shilajit's own safety record look like?
  • Common questions about shilajit and blood thinners

Where does the shilajit and blood thinner warning actually come from?

Search "fulvic acid blood thinner" and a drug interaction database will likely rate the combination Moderate. That rating looks authoritative. It rests on exactly one paper, and the paper is not about shilajit.

The paper is Lu and colleagues (1990), published in Thrombosis Research. The researchers were studying Blackfoot disease, a circulatory illness tied to arsenic contaminated well water in one region of Taiwan. To model what was happening in the local drinking water, they built humic and fulvic acids in the lab by oxidizing protocatechuic acid, using arsenic as a chemical promoter in the reaction. The resulting compounds were then added directly to pooled human plasma, outside the body, in a test tube.

Three steps removed from an actual supplement

Lay the chain out and the distance becomes obvious:

  • A synthetic compound, not the fulvic acid found in shilajit
  • Made using arsenic as a reaction promoter
  • Added to isolated plasma, never swallowed, never digested
  • Never tested in a living animal of any kind, let alone a person
What did the original 1990s lab study measure?

What did the original 1990s lab study measure?

The 1990 paper and two companion papers from the same research group all measured prothrombin time, the standard lab test for how quickly plasma clots, after adding humic or fulvic compounds directly to it.

  • Lu and colleagues (1990, Thrombosis Research, well water humic substances) found shortened clotting time at 0.5 to 5 milligrams per milliliter, and only lengthened clotting at the much higher range of 10 to 20 milligrams per milliliter.
  • Lu and colleagues (1994, Environmental Geochemistry and Health) found commercial humic acid, well water humic substances, and lignin all shortened clotting time at concentrations as low as 0.005 to 0.05 milligrams per milliliter.
  • The original 1990 paper on arsenic promoted synthetic compounds found shortened prothrombin time at the concentration most commonly cited.

Every one of these three results came from a test tube holding isolated plasma. None of them involved an animal or a person swallowing anything.

The direction that got flattened into a warning

Here is the detail that disappears by the time it reaches a drug interaction summary. The lab effect ran in both directions depending on concentration, and the low dose direction was faster clotting, not slower. A warning that fulvic acid "might increase how quickly blood clots" would be the more literal reading of the 1990 data than a warning that it thins the blood. Somewhere between the original paper and the modern supplement database, that nuance was lost.

Did the effect even point the direction people assume?

What happened when researchers tried it by mouth in a living animal?

Only one study has ever given a humic substance orally to a living animal and then measured clotting. Buczko and colleagues (1993, Acta Poloniae Pharmaceutica) dosed rats with Tolpa Peat Preparation, a humic extract made from peat rather than shilajit, at 100 to 300 milligrams per kilogram by mouth.

The result was straightforward. The extract had no influence on bleeding time, clotting time, thrombin time, or prothrombin time, and no effect on platelet count or ADP-induced platelet aggregation. The researchers also ran a two-week dosing arm at 100 milligrams per kilogram and found the same outcome. Nothing moved on any of the four measures that matter for a clotting question.

That is the only data point in the published literature testing an oral humic substance, in a living body, against the exact lab measurements the online warning is built on. It came back clean.

How much fulvic acid would it take to match the lab concentration?

This is the part the warning skips. A test tube concentration of 10 milligrams per milliliter sounds abstract until it becomes an actual amount of fulvic acid in a person's bloodstream.

An average adult carries roughly 2,500 milliliters of plasma. Reaching 10 milligrams per milliliter inside that volume would take about 25 grams of fulvic acid circulating at once, fully absorbed, all in a single moment. Optimum's tablets carry 200 milligrams of fulvic acid each, so that figure works out to roughly 125 tablets entering the bloodstream simultaneously, not across a day, not absorbed gradually through digestion.

Test tube warning concentration Optimum's actual serving
Fulvic acid amount About 25 grams in 2,500 mL of plasma at once 200 to 400 mg per serving
Route Added directly to isolated plasma Swallowed, absorbed gradually through digestion
Equivalent in tablets About 125 tablets, all at once 1 to 2 tablets
Species tested directly None, isolated human plasma only None tested against an anticoagulant

The oral rat study gives a more honest comparison than the test tube math. Using the standard body surface area conversion from rat to human, the 300 milligram per kilogram dose that produced no clotting change works out to roughly 2.9 grams a day for a 60 kilogram woman. That is still about seven times Optimum's daily serving, and clotting still did not move.

What does shilajit's own safety record look like?

Separate from the blood thinner question, shilajit carries a broader published safety record worth stating plainly rather than hedging around.

  • Zero serious adverse events reported across published human shilajit trials
  • Optimum Shilajit is sourced from the Altai mountains, never a region associated with the Blackfoot disease well water research above
  • Every batch is third-party tested for heavy metals before it reaches a box
  • Every batch is tested for its actual fulvic acid percentage, so the dose on the label matches the dose in the tablet

Fulvic acid also carries no documented interaction warning for the blood pressure or cholesterol medications a woman this age is statistically more likely to be taking, which is part of why Optimum tests every batch rather than asking anyone to take a label on faith.

Where does this leave an honest answer?

No documented interaction between shilajit and an anticoagulant exists in a person. The warning in circulation traces to test tube chemistry on synthetic, arsenic-promoted compounds built to model contaminated well water, not to shilajit and not to a living bloodstream. The one time anyone gave an oral humic extract to a living animal, at several times a normal serving, the clotting measurements that matter did not move.

That is a different claim than "proven safe with every medication." It is an honest accounting of what has and has not been tested, stated plainly instead of hidden behind a vague caution borrowed from an unrelated compound.

Common questions about shilajit and blood thinners

Does shilajit thin the blood?

No human or animal study has ever tested shilajit itself against an anticoagulant. The warning some supplement databases print for fulvic acid traces to 1990s test tube experiments on synthetic humic and fulvic compounds, not to shilajit, and not to a person or an animal taking it by mouth.

Where does the fulvic acid and blood thinner warning come from?

Natural Medicines and similar databases cite one paper, Lu and colleagues (1990, Thrombosis Research), in which synthetic humic and fulvic acids were made in a lab using arsenic as a promoter, then added directly to human plasma in a test tube. That is not shilajit, and it is not oral dosing in a living body.

What did that original test tube study actually find?

It found the plasma clotted faster, not slower, at the concentration most often cited. A related paper from the same researchers found the opposite effect, slower clotting, only at much higher concentrations. The lab result runs in both directions depending on dose, which is the opposite of a clean warning.

Is there any study of this in a living animal?

Yes, one. Buczko and colleagues (1993, Acta Poloniae Pharmaceutica) gave rats a humic peat extract by mouth for two weeks, at a dose equivalent to roughly seven times Optimum's daily serving in a 60 kilogram woman. Bleeding time, clotting time, prothrombin time, and platelet function were all unchanged.

Is shilajit safe to take overall?

Across published human shilajit trials, researchers have reported zero serious adverse events. Optimum Shilajit comes from the Altai mountains and every batch is third-party tested for heavy metals and fulvic acid content before it reaches a box.

Optimum Shilajit box

Optimum's own approach to safety

Optimum Shilajit is sourced from the Altai mountains and every batch carries a current certificate of analysis for heavy metals and fulvic acid percentage, posted for anyone to check before they decide what goes in their body. That transparency is the real answer to a safety question, a lab report rather than a guess. If you are weighing whether shilajit fits your own health picture, the full research behind it is laid out at .

See Optimum Shilajit

Sources

  1. Lu FJ, et al. "Humic acid and arsenic in the etiology of Blackfoot disease: effects on plasma prothrombin time." Thrombosis Research. 1990;58(6):537-541. https://pubmed.ncbi.nlm.nih.gov/2143602/
  2. Lu FJ, et al. "Effect of humic substances on plasma clotting time." Thrombosis Research. 1990;57(5):747-753. https://pubmed.ncbi.nlm.nih.gov/2140208/
  3. Lu FJ, et al. "Humic substances and clotting time, a well water study." Environmental Geochemistry and Health. 1994;16(2):65-69. https://pubmed.ncbi.nlm.nih.gov/24197033/
  4. Buczko W, et al. "Effects of Tolpa Peat Preparation on hemostasis in rats." Acta Poloniae Pharmaceutica. 1993;50(6):507-511. https://pubmed.ncbi.nlm.nih.gov/8067264/